基本信息
views: 126
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Louis is the CSO and Management Board Member of JJP Biologics. Louis obtained his Ph.D. in Biochemistry at the University of Amsterdam. He was founder of various companies focused around the generation and development therapeutic monoclonal antibodies, primarily in the field of cancer and inflammation. In 2003, he was one of the founders of Bioceros BV, now Polpharma Biologics Utrecht, where he currently holds the position of Principle Scientific Advisor. In addition, he held positions as CSO for MacroZyme BV, 4AZA Bioscience NV, FF Pharma and VP preclinical for PanGenetics BV and Tanox. Louis is an author of over 340 publications in international scientific journals in the field of medical biotechnology and an inventor at more than 20 patent applications.
Research Interests
Papers共 515 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Kevin Englebert,Anaelle Taquin,Abdulkader Azouz,Valérie Acolty, Sylvie Vande Velde, Marie Vanhollebeke, Hadrien Innes,Louis Boon,Tibor Keler,Oberdan Leo,Stanislas Goriely,Muriel Moser,
Cell Reportsno. 3 (2024): 113824-113824
Kevin Englebert,Anaelle Taquin,Abdulkader Azouz,Valerie Acolty, Sylvie Vande Velde, Marie Vanhollebeke, Hadrien Innes,Louis Boon,Tibor Keler,Oberdan Leo,Stanislas Goriely,Muriel Moser,
CELL REPORTSno. 3 (2024)
Diede Houbaert, Apostolos Panagiotis Nikolakopoulos,Kathryn A. Jacobs,Odeta Meçe,Jana Roels,Gautam Shankar,Madhur Agrawal,Sanket More, Maarten Ganne,Kristine Rillaerts,Louis Boon, Magdalena Swoboda,
Cell Reportsno. 4 (2024): 114020-114020
Cancer immunology, immunotherapy : CIIno. 1 (2024): 16-16
SCIENTIFIC DATAno. 1 (2024): 448-448
FRONTIERS IN IMMUNOLOGY (2024): 1373745-1373745
biorxiv(2024)
NATURE MEDICINEno. 6 (2024): 1667-1679
Load More
Author Statistics
#Papers: 470
#Citation: 20817
H-Index: 76
G-Index: 125
Sociability: 8
Diversity: 0
Activity: 3
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn